Eledon Pharmaceuticals, Inc. (ELDN) Ownership

NASDAQ: ELDNTop holders, insider trades and short interest.

ELDN ownership summary

as of October 18, 2026
Institutions
58.7%
of shares outstanding
Insiders
0.33%
of shares outstanding
Shares outstanding
81.3M
Float
74.6M
shares available to trade
Short interest
9.66%
7.8M shares short
Days to cover
8.20
short interest down 5.0% vs prior month
  • Institutions 58.66%
  • Insiders 0.33%
  • Other investors 41.01%

ELDN top institutional holders

20 largest
Eledon Pharmaceuticals, Inc. top institutional holders
#Holder% of sharesSharesValueChangeReported
1Bvf Inc7.74%6.3M$13.4M—June 30, 2026
2BlackRock Inc6.31%5.1M$10.9M+741,597 (+16.9%)June 30, 2026
3Defilade Capital Management, L.P.4.34%3.5M$7.5M−38,789 (−1.1%)June 30, 2026
4Vanguard Capital Management, LLC4.21%3.4M$7.3M+124,089 (+3.8%)June 30, 2026
5The Goldman Sachs Group Inc3.09%2.5M$5.3M+2.1M (+578.3%)June 30, 2026
6Ensign Peak Advisors Inc2.59%2.1M$4.5M−363,695 (−14.8%)June 30, 2026
7Geode Capital Management, LLC2.41%2.0M$4.2M+164,818 (+9.2%)June 30, 2026
8Catalio Capital Management, LP2.09%1.7M$3.6M+55,255 (+3.4%)June 30, 2026
9State Street Corp2.00%1.6M$3.5M+467,298 (+40.5%)June 30, 2026
10Zimmer Partners LP1.96%1.6M$3.4M−278,401 (−14.8%)June 30, 2026
11Sphera Funds Management Ltd.1.47%1.2M$2.5M−580,944 (−32.8%)June 30, 2026
12Awm Investment Company Inc1.35%1.1M$2.3M—June 30, 2026
13UBS Group AG1.29%1.0M$2.2M+500,798 (+91.5%)June 30, 2026
14Kingdon Capital Management LLC1.28%1.0M$2.2M—June 30, 2026
15Millennium Management LLC1.21%980K$2.1M+979,712 (0.0%)June 30, 2026
16Bank of America Corp1.09%883K$1.9M+13,553 (+1.6%)June 30, 2026
17ADAR1 Capital Management LLC0.80%648K$1.4M−326,609 (−33.5%)June 30, 2026
1822NW, LP0.78%636K$1.4M—June 30, 2026
19Northern Trust Corp0.76%616K$1.3M+72,557 (+13.3%)June 30, 2026
20AQR Capital Management LLC0.71%581K$1.2M+408,611 (+237.0%)June 30, 2026

Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 11 holders added 5.7M shares and 5 cut 1.6M.

ELDN top mutual fund and ETF holders

20 largest
Eledon Pharmaceuticals, Inc. top fund holders
#Holder% of sharesSharesValueChangeReported
1Vanguard MStar Total Stk Mkt Idx Invest3.06%2.5M$5.3M—August 31, 2026
2iShares Russell 2000 ETF2.52%2.0M$4.4M−23,616 (−1.1%)September 30, 2026
3Fidelity Small Cap Index1.03%839K$1.8M+3,059 (+0.4%)July 31, 2026
4iShares Russell 2000 Growth ETF0.90%730K$1.6M−924 (−0.1%)September 30, 2026
5Vanguard Russell 2000 ETF0.54%442K$940,497+8,760 (+2.0%)August 31, 2026
6Fidelity Extended Market Index0.45%367K$780,986+11,618 (+3.3%)August 31, 2026
7Goldman Sachs Small Cap Eq Insghts Instl0.38%312K$664,545+133,138 (+74.4%)July 31, 2026
8Goldman Sachs Small Cp Val Insghts Instl0.35%286K$609,206−42,073 (−12.8%)July 31, 2026
9GS US Sm Cp CORE Eq Base Inc USD Snap0.34%278K$591,576−41,502 (−13.0%)July 31, 2026
10iShares Micro-Cap ETF0.30%243K$517,794−1,677 (−0.7%)September 30, 2026
11Dimensional US Small Cap ETF0.24%197K$419,391—September 30, 2026
12Schwab Small Cap Index0.23%187K$399,198—August 31, 2026
13Stt Strt SPDR® Russell2000 US SmCapETF0.22%175K$372,479+8,367 (+5.0%)August 31, 2026
14Fidelity Total Market Index0.17%142K$301,474—August 31, 2026
15iShares Russell 2000 Small-Cap Idx Instl0.17%135K$287,450—August 31, 2026
16Goldman Sachs Small Cap Gr Insghts Instl0.16%130K$275,937+78,018 (+151.4%)July 31, 2026
17Fidelity Series Total Market Index0.15%119K$253,689—August 31, 2026
18Goldman Sachs ActiveBeta® US SmCp Eq ETF0.14%112K$238,366—September 30, 2026
19Nuveen Small Cap Blend Idx R60.13%103K$218,685—August 31, 2026
20DFA US Micro Cap I0.11%92K$196,292—August 31, 2026

Funds report holdings monthly or quarterly; dates differ by fund.

ELDN insider transactions

latest 1
Eledon Pharmaceuticals, Inc. insider transactions
DateNameTransactionPriceSharesValue
2021-12-20David-Alexandre C GrosBuy$4.482,000$8,960

Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.

ELDN shares outstanding

Shares outstanding

Year-end shares outstanding, adjusted for splits.

Who owns ELDN

Institutional investors own 58.7% of Eledon Pharmaceuticals's shares and insiders 0.33%. The largest holder is Bvf Inc with 7.74% of the shares (6.3M), as of June 30, 2026. Among the top 20 institutions, 11 added shares and 5 reduced their stake in the latest filings. Short interest is 9.66% of the float, or 8.20 days of average trading volume. The share count rose 2,940.3% since 2014.

Related: ELDN analyst forecast, ELDN key metrics. See the ELDN stock overview for the latest quote and news.

ELDN ownership FAQ

Who owns the most Eledon Pharmaceuticals stock?

The largest shareholders of Eledon Pharmaceuticals are Bvf Inc (7.74%), BlackRock Inc (6.31%), Defilade Capital Management, L.P. (4.34%), Vanguard Capital Management, LLC (4.21%), The Goldman Sachs Group Inc (3.09%).

What percentage of Eledon Pharmaceuticals is owned by institutions?

Institutions hold 58.7% of Eledon Pharmaceuticals's shares outstanding; insiders hold 0.33%.

Which funds own Eledon Pharmaceuticals?

The largest fund holders of Eledon Pharmaceuticals are Vanguard MStar Total Stk Mkt Idx Invest (3.06%), iShares Russell 2000 ETF (2.52%), Fidelity Small Cap Index (1.03%), iShares Russell 2000 Growth ETF (0.90%), Vanguard Russell 2000 ETF (0.54%).

What is Eledon Pharmaceuticals's short interest?

7.8M shares of Eledon Pharmaceuticals were sold short, 9.66% of the float; at the average daily volume it would take 8.20 days to cover.

Are insiders buying or selling Eledon Pharmaceuticals?

Of the latest 1 reported insider transactions in Eledon Pharmaceuticals (since December 20, 2021), 1 were purchases and 0 were sales.

How many shares of Eledon Pharmaceuticals are outstanding?

Eledon Pharmaceuticals has 81.3M shares outstanding, of which 74.6M are in the public float.

Biotechnology: ownership